NO961622L - Inhibering av fotospalting av 3-substituerte 2-oksindoler - Google Patents

Inhibering av fotospalting av 3-substituerte 2-oksindoler

Info

Publication number
NO961622L
NO961622L NO961622A NO961622A NO961622L NO 961622 L NO961622 L NO 961622L NO 961622 A NO961622 A NO 961622A NO 961622 A NO961622 A NO 961622A NO 961622 L NO961622 L NO 961622L
Authority
NO
Norway
Prior art keywords
substituted
oxindoles
cleavage
inhibition
photo
Prior art date
Application number
NO961622A
Other languages
English (en)
Other versions
NO961622D0 (no
Inventor
Willard C Newlin Jr
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO961622D0 publication Critical patent/NO961622D0/no
Publication of NO961622L publication Critical patent/NO961622L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Oppfinnelsen angår beskyttelsen av visse 3-substituerte- 2-oksindol-l-karboksamider med formel og deres farmasøytisk akseptable basesalter, hvor X er H, Cl eller F; Y er H eller Cl; og R er benzyl eller tienyl, hver eventuelt substituert med Cl eller F, mot en spaltning i nærvær av lys.
NO961622A 1995-04-24 1996-04-23 Inhibering av fotospalting av 3-substituerte 2-oksindoler NO961622L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (2)

Publication Number Publication Date
NO961622D0 NO961622D0 (no) 1996-04-23
NO961622L true NO961622L (no) 1996-10-25

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961622A NO961622L (no) 1995-04-24 1996-04-23 Inhibering av fotospalting av 3-substituerte 2-oksindoler

Country Status (30)

Country Link
EP (1) EP0827399A1 (no)
JP (1) JPH10506635A (no)
KR (1) KR100189585B1 (no)
CN (1) CN1053667C (no)
AP (1) AP607A (no)
AR (1) AR002728A1 (no)
AU (1) AU692378B2 (no)
BG (1) BG100531A (no)
BR (1) BR9602024A (no)
CO (1) CO4700418A1 (no)
FI (1) FI973988A0 (no)
HR (1) HRP960194A2 (no)
HU (1) HU216544B (no)
IL (1) IL117969A0 (no)
IS (1) IS4339A (no)
MA (1) MA23848A1 (no)
NO (1) NO961622L (no)
NZ (1) NZ286432A (no)
OA (1) OA10286A (no)
PE (1) PE34397A1 (no)
RO (1) RO113305B1 (no)
RU (1) RU2109510C1 (no)
SG (1) SG64924A1 (no)
SI (1) SI9600133A (no)
SK (1) SK51296A3 (no)
TR (1) TR199600300A2 (no)
UA (1) UA42739C2 (no)
WO (1) WO1996033701A1 (no)
YU (1) YU25096A (no)
ZA (1) ZA963210B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111526730B (zh) 2017-12-29 2024-02-23 卡夫食品集团品牌有限责任公司 使用天然稳定剂改善的水包油乳液的氧化稳定性

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
HUP9601057A2 (en) 1997-04-28
AP607A (en) 1997-08-27
MA23848A1 (fr) 1996-12-31
AU692378B2 (en) 1998-06-04
UA42739C2 (uk) 2001-11-15
FI973988L (fi) 1997-10-17
KR100189585B1 (ko) 1999-06-01
RO113305B1 (ro) 1998-06-30
HUP9601057A3 (en) 1997-05-28
CN1139110A (zh) 1997-01-01
SK51296A3 (en) 1997-04-09
IS4339A (is) 1996-10-25
BR9602024A (pt) 1998-10-06
CO4700418A1 (es) 1998-12-29
HRP960194A2 (en) 1998-02-28
AU5085196A (en) 1996-11-07
TR199600300A2 (tr) 1996-11-21
CN1053667C (zh) 2000-06-21
AR002728A1 (es) 1998-04-29
ZA963210B (en) 1997-10-23
EP0827399A1 (en) 1998-03-11
AP9600787A0 (en) 1996-04-30
KR960037656A (ko) 1996-11-19
RU2109510C1 (ru) 1998-04-27
FI973988A7 (fi) 1997-10-17
HU216544B (hu) 1999-07-28
HU9601057D0 (en) 1996-06-28
JPH10506635A (ja) 1998-06-30
YU25096A (sh) 1998-08-14
SG64924A1 (en) 1999-05-25
NO961622D0 (no) 1996-04-23
PE34397A1 (es) 1997-09-29
SI9600133A (en) 1996-10-31
FI973988A0 (fi) 1997-10-17
NZ286432A (en) 1998-05-27
IL117969A0 (en) 1996-08-04
OA10286A (en) 1997-09-19
WO1996033701A1 (en) 1996-10-31
BG100531A (bg) 1997-06-30

Similar Documents

Publication Publication Date Title
NO2004004I1 (no) Bortezomib eller en farmasøytisk akseptabel ester derav, eventuelt i form av et farmasøytisk akseptabelt salt derav
DK0658198T3 (da) Multicistroniske ekspressionsenheder samt deres anvendelse
NO975740L (no) Arylsulfonylaminobenzenderivater og deres anvendelse som faktor Xa-inhibitorer
DK0925319T3 (da) Triazinpolymerer og deres anvendelse i elektroluminescerende arrangementer
ATE194335T1 (de) 4,5-diaryloxazol-derivate
FI942166L (fi) Menetelmiä restenoosin ehkäisemiseksi
MY114393A (en) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1, 3-propanediol derivatives
FI940659A7 (fi) Heterosyklisesti substituoituja fenyylisykloheksaanikarboksyylihappojohdannaisia
ATE80302T1 (de) Verwendung von polymeren bei einer behandlung.
NO995245L (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
TW362096B (en) Novel piperidine derivatives and the process for preparing the same
IT1295933B1 (it) 2-(2'-idrossifenil)benzotriazoli e procedimento per la loro preparazione
FI961974A7 (fi) Epäorgaanisten pigmenttien käsittely karboksimetyyliselluloosayhdisteillä
DE69903053D1 (de) Diaminocyclobuten-3,4-dionderivate, deren herstellung und deren verwendung
FI941712A7 (fi) Heterosykliset iminobismetyleenibisfosfonihappojohdannaiset
DE69213862D1 (de) Herstellung von Aluminoxanen
DE69415801D1 (de) Not-schutzhaus
NO961236D0 (no) Pyrrolodiazin-derivater som stabilisatorer for klorholdige polymerisater
DE69325073D1 (de) Borazinderivate von Hydridopolysilazanpolymeren
DE69327813D1 (de) Alpha-Glucosyl-Catecholaminderivate, ihre Salze, Herstellung und Verwendung
DE59405004D1 (de) Herstellung von 2-H-Heptafluorpropan
FI941230A7 (fi) Heterotrisyklisesti substituoituja fenyylisykloheksaanikarboksyylihappojohdannaisia
DE69611303D1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
AU3721389A (en) Glycerin derivative and its pharmacological use
FIU930584U0 (fi) Anlaeggning i samband med styrningen av en vira